What does Clinical Projects International do?

Clinical Projects International is a research organisation in Niel. Public Limited, started on 29 November 2011, 1 establishment.

What is the address of Clinical Projects International?

The registered office of Clinical Projects International is located at Galileilaan 21 box 4, 2845 Niel.

Is Clinical Projects International still active?

Yes. According to the CBE (30 October 2026) Clinical Projects International is active, legal situation “Normale toestand”, started on 29 November 2011.

Is Clinical Projects International registered on Peppol?

Yes, Clinical Projects International is registered on the Peppol network with ID 0208:0841395024.

What is the enterprise number of Clinical Projects International?

The enterprise number of Clinical Projects International is BE0841395024.

When was Clinical Projects International founded?

Clinical Projects International was founded on 29 November 2011.

Is Clinical Projects International a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 November 2011; 4 annual accounts filed, latest fiscal year 2024; 4 directors known from the annual account.

How much profit did Clinical Projects International make in 2024?

Clinical Projects International posted a profit after taxes of € 9,100 in financial year 2024.

What is the revenue of Clinical Projects International?

As a small company, Clinical Projects International is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 129,911.

How many employees does Clinical Projects International have?

According to the 2024 annual accounts, Clinical Projects International has 0 full-time equivalents (FTE).

Clinical Projects International (Public Limited) - Niel

Q: Who are the directors of Clinical Projects International?

According to the 2024 annual accounts, the directors of Clinical Projects International are: Willem Van Cauter, Philip Loquet, Christel D'Haese, Gonzalez Antonia Rodriguez.

Dossier Clinical Projects International, printed on 30 October 2026 from databakkes.be/en/0841395024/clinical-projects-international. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Clinical Projects International from Niel, company number BE0841395024, closed financial year 2024 with a result of € 9,100 after tax. For that financial year Clinical Projects International recorded a gross margin of € 129,911 and equity of € 1.4 million. Compared with financial year 2023, the result moved from € -228,358 to € 9,100. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 26, 2025.

What it is worth Growing

€ 1.4 million

▲ 1% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 9,100

▲ still € 228,358 loss in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 239,187

▲ 45% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € -493,701.

People and assets in 2024

Full-time equivalents

▼ 0.5 vs 2023

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 6,280

▼ 20% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 700,000

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 72,752

▼ 60% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,409

▲ 9% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ -61,284 Gross margin 2021: € -61,284 First fiscal year in the series	€ 122,805 Gross margin 2022: € 122,805 ▲ € 184,089 vs 2021 (€ -61,284) Favourable step	€ -80,873 Gross margin 2023: € -80,873 ▼ € 203,677 vs 2022 (€ 122,805) Unfavourable step	€ 129,911 Gross margin 2024: € 129,911 ▲ € 210,784 vs 2023 (€ -80,873) Favourable step	▲ € 210,784
Profit after taxes	€ -82,882 Profit after taxes 2021: € -82,882 First fiscal year in the series	€ -104,120 Profit after taxes 2022: € -104,120 ▼ € 21,237 vs 2021 (€ -82,882) Unfavourable step	€ -228,358 Profit after taxes 2023: € -228,358 ▼ € 124,239 vs 2022 (€ -104,120) Unfavourable step	€ 9,100 Profit after taxes 2024: € 9,100 ▲ € 237,458 vs 2023 (€ -228,358) Favourable step	▲ € 237,458
Equity	€ 1,729,678 Equity 2021: € 1,729,678 First fiscal year in the series	€ 1,625,558 Equity 2022: € 1,625,558 ▼ 6% vs 2021 (€ 1,729,678) Unfavourable step	€ 1,397,200 Equity 2023: € 1,397,200 ▼ 14% vs 2022 (€ 1,625,558) Unfavourable step	€ 1,406,299 Equity 2024: € 1,406,299 ▲ 1% vs 2023 (€ 1,397,200) Favourable step	▲ 1%
Total debts	€ 283,448 Total debts 2021: € 283,448 First fiscal year in the series	€ 944,995 Total debts 2022: € 944,995 ▲ 233% vs 2021 (€ 283,448) Unfavourable step	€ 2,787,184 Total debts 2023: € 2,787,184 ▲ 195% vs 2022 (€ 944,995) Unfavourable step	€ 3,723,132 Total debts 2024: € 3,723,132 ▲ 34% vs 2023 (€ 2,787,184) Unfavourable step	▲ 34%
Cash	€ 518,884 Cash 2021: € 518,884 First fiscal year in the series	€ 53,180 Cash 2022: € 53,180 ▼ 90% vs 2021 (€ 518,884) Unfavourable step	€ 164,517 Cash 2023: € 164,517 ▲ 209% vs 2022 (€ 53,180) Favourable step	€ 239,187 Cash 2024: € 239,187 ▲ 45% vs 2023 (€ 164,517) Favourable step	▲ 45%
Land & buildings	€ 533,573 Land & buildings 2021: € 533,573 First fiscal year in the series	€ 1,035,219 Land & buildings 2022: € 1,035,219 ▲ 94% vs 2021 (€ 533,573) Unchanged	€ 1,093,507 Land & buildings 2023: € 1,093,507 ▲ 6% vs 2022 (€ 1,035,219) Unchanged	€ 1,128,381 Land & buildings 2024: € 1,128,381 ▲ 3% vs 2023 (€ 1,093,507) Unchanged	▲ 3%
Retained profit	€ -170,322 Retained profit 2021: € -170,322 First fiscal year in the series	€ -274,442 Retained profit 2022: € -274,442 ▼ € 104,120 vs 2021 (€ -170,322) Unfavourable step	€ -502,800 Retained profit 2023: € -502,800 ▼ € 228,358 vs 2022 (€ -274,442) Unfavourable step	€ -493,701 Retained profit 2024: € -493,701 ▲ € 9,100 vs 2023 (€ -502,800) Favourable step	▲ € 9,100
Bank debt	€ 250,048 Bank debt 2021: € 250,048 First fiscal year in the series	€ 700,048 Bank debt 2022: € 700,048 ▲ 180% vs 2021 (€ 250,048) Unfavourable step	€ 700,000 Bank debt 2023: € 700,000 Unchanged (€ 700,048) Favourable step	€ 700,000 Bank debt 2024: € 700,000 Unchanged (€ 700,000) Unchanged
Balance sheet total	€ 2,013,126 Balance sheet total 2021: € 2,013,126 First fiscal year in the series	€ 2,570,553 Balance sheet total 2022: € 2,570,553 ▲ 28% vs 2021 (€ 2,013,126) Unchanged	€ 4,184,383 Balance sheet total 2023: € 4,184,383 ▲ 63% vs 2022 (€ 2,570,553) Unchanged	€ 5,129,431 Balance sheet total 2024: € 5,129,431 ▲ 23% vs 2023 (€ 4,184,383) Unchanged	▲ 23%
Employees (FTE)	-	-	0.5 Employees (FTE) 2023: 0.5 First fiscal year in the series	0 Employees (FTE) 2024: 0 ▼ 0.5 vs 2023 (0.5) Unchanged	▼ 0.5

Key figures of Clinical Projects International, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Clinical Projects International?

What happened at Clinical Projects International in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 26, 2025 New annual accounts for financial year 2024: profit of € 9,100. filed late Source: NBB ↗
2021 Christel D'Haese became a director. NBB
2021 Willem Van Cauter became a director. NBB
2021 Philip Loquet became a director. NBB
2021 Gonzalez Antonia Rodriguez became a director. NBB
Nov 29, 2011 New establishment in Niel. KBO
Nov 29, 2011 Start of the company according to the CBE. KBO

In short

From € 82,882 loss in 2021 to € 9,100 profit in 2024.

Paid € 1,190 in corporate taxes since 2021.

Best year ever: 2024, with € 9,100 profit.

Original PDFs at the National Bank ↗

Management

Willem Van Cauter Philip Loquet Christel D'Haese Gonzalez Antonia Rodriguez

Dokter Philip Loquet

Clinical Projects International

Behind Clinical Projects International are Willem Van Cauter, Philip Loquet, Christel D'Haese and Gonzalez Antonia Rodriguez. Philip Loquet is also behind Dokter Philip Loquet.

Directors

According to the 2024 annual accounts

Willem Van Cauter

Director

since 2021

Philip Loquet

Director

Also active at: Dokter Philip Loquet

since 2021

Christel D'Haese

Director

since 2021

Gonzalez Antonia Rodriguez

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Galileilaan 21 box 4

2845 Niel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

Cosmos Laboratory Equipment

€ 136,269 gross margin · 2025

INFODATA

€ 11,409 gross margin · 2025

anicells

€ 1.2 million gross margin · 2026

Vereniging van Mede-eigenaars van het gebouw Hypocratesgebouw Galileilaan 21 te Niel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0841.395.024

VAT number

BE 0841.395.024

Registered office

Galileilaan 21 bus 4, 2845 Niel

Names & denominations

Clinical Projects International · CPI

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

29 November 2011

Peppol

Active · Active since 27 Mar 2026

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Clinical Projects International

Financials

What happened to Clinical Projects International?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions